Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations

Oncogene

Volumn 14, Issue 3, 1997, Pages 265-275

  Rossel, Mireille ^a   Pasini, Andrea ^a   Chappuis, Sophie ^a   Geneste, Olivier ^a   Fournier, Laurence ^a   Schuffenecker, Isabelle ^b   Takahashi, Masahide ^c   Van Grunsven, Leo A ^d   Urdiales, José Luis ^d   Rudkin, Brian B ^d   Lenoir, Gilbert M ^a,b   Billaud, Marc ^a  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITÉ DE LYON   (France)

Author keywords

Isoforms; MEN 2; RET proto oncogene; Tyrosine kinase

Indexed keywords

ISOPROTEIN; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROBLAST; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; MOUSE; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NONHUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTO ONCOGENE; RAT; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA;

ANIMALIA;

EID: 8044253411     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200831     Document Type: Article

References (55)

1. Asai N, Iwashita T, Matsuyama M and Takahashi M. (1995). Mol. Cell. Biol., 15, 1613-1619.
2. Attié T, Pelet A, Edery P, Eng C, Mulligan LM, Amiel J, Boutrand L, Beldjord C, Nihoul-Fékété C, Munnich A, Ponder BAJ and Lyonnet S. (1995). Hum. Mol. Genet., 4, 1381-1386.
3. Bolande R. (1974). Hum. Pathol., 5, 409-429.
4. Bolino A, Schuffenecker I, Luo Y, Seri M, Silengo M, Tocco M, Chabrier G, Houdent C, Murat A, Schlumberger M, Tourniaire J, Lenoir GM and Romeo G. (1995). Oncogene, 10, 2415-2419.
5. Borello MG, Smith DP, Pasini B, Bongarzone I, Greco A, Lorenzo MJ, Arighi E, Miranda C, Eng C, Alberti L, Bocciardi R, Mondellini P, Scopsi L, Romeo G, Ponder BAJ and Pierotti MA. (1995). Oncogene, 11, 2419-2427.
6. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells Jr SA, Goodfellow PJ and Donis-Keller H. (1994). Proc. Natl. Acad. Sci. USA, 91, 1579-1583.
7. Cowley S, Paterson H, Kemp P and Marshall CJ. (1994). Cell, 77, 841-852.
8. DeLellis RA. (1995). Lab. Investig., 72, 494-505.
9. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow PJ and Wells Jr SA. (1993). Hum. Mol. Genet., 2, 851-856.
10. Durbec P, Marcos-Gutierrez C, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M, Sariola H and Pachnis V. (1996). Nature, 381, 789-793.
11. Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GFW, Jackson CE, Tunnacliffe A and Ponder BAJ. (1994). Hum. Mol. Genet., 3, 234-241.
12. Eng C, Smith DP, Mulligan LM, Healey CS, Zvelebil MJ, Stonehouse TJ, Ponder MA, Jackson CE, Waterfield MD and Ponder BAJ. (1995). Oncogene, 10, 509-513.
13. Fournier E, Dubreuil P, Birnbaum D and Borg JP. (1995). Oncogene, 11, 921-931.
14. Friedrich G and Soriano P. (1991). Genes & Dev., 5, 1513-1523.
15. Ghattas IR, Sanes JR and Majors JE. (1991). Mol. Cell. Biol., 11, 5848-5859.
16. Goodfellow PJ. (1994). Cur. Opin. Genet. Dev., 4, 446-452.
17. Hofstra RMW, Landvaster RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Höppener JWM, van Hamstel HKP, Romeo G, Lips CJM and Buys CHCHM. (1994). Nature, 367, 375-376.
18. Iwashita T, Asai N, Murakami H, Matsuyama M and Takahashi M. (1996). Oncogene, 12, 481-487.
19. Jing S, Duanzhi W, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Copples R, Lois JC, Hu S, Altrock BW and Fox GM. (1996). Cell, 85, 1113-1124.
20. Kozak M. (1989). J. Cell. Biol., 108, 229-241.
21. Lamballe F, Tapley P and Barbacid M. (1993). EMBO J., 12, 3083-3094.
22. Liu X, Vega QC, Deckers RA, Pandey A, Worby CA and Dixon JE. (1996). J. Biol. Chem., 271, 5309-5312.
23. Lorenzo MJ, Eng C, Mulligan LM, Stonehouse TJ, Healey CS, Ponder BAJ and Smith DP. (1995). Oncogene, 10, 1377-1383.
24. Marshall CJ. (1995). Cell, 80, 179-185.
25. Miyasaka T, Sternberg DW, Miyasaka J, Sherline P and Saltiel AR. (1991). Proc. Natl. Acad. Sci. USA, 88, 2653-2657.
26. Miyazaki K, Asai N, Iwashita T, Taniguchi M, Isomura T, Funahashi H, Takagi H, Matsuyama M and Takahashi M. (1993). Biochem. Biophys. Res. Commun., 193, 565-570.
27. Morgenstern JP and Land H. (1990a). Nucl. Acids Res., 18, 1068.
28. Morgenstern JP and Land H. (1990b). Nucl. Acids. Res., 18, 3587.
29. Mountfrod PS and Smith AG. (1995). Trends Genet., 11, 179-184.
30. Mueneke M and Schell U. (1995). Trends Genet., 11, 308-313.
31. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A and Ponder BAJ. (1993). Nature, 363, 458-460.
32. Mulligan LM, Eng C, Healey CS, Clayton D, Kwok JBJ, Gardner E, Ponder MA, Frilling A, Jackson CE, Lehnert H, Neumann HPH, Thibodeau SN and Ponder BAJ. (1994). Nature Genet., 6, 70-74.
33. Myers SM, Eng C, Ponder BAJ and Mulligan LM. (1995). Oncogene, 11, 2039-2045.
34. Pachnis V, Mankoo B and Costantini F. (1993). Development, 119, 1005-1017.
35. Pasini B, Ceccherini I and Romeo G. (1996). Trends in Genet., 12, 138-144.
36. Pawson T. (1995). Nature, 373, 573-580.
37. Pear WS, Nolan GP, Scott ML and Baltimore D. (1993). Proc. Natl. Acad. Sci. USA, 90, 8392-8396.
38. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD and Downward J. (1994). Nature, 370, 527-532.
39. Rossel M, Schuffenecker I, Schlumberger M, Bonnardel C, Modigliani E, Gardet P, Navarro J, Luo Y, Romeo G, Lenoir GM and Billaud M. (1995). Hum. Genet., 95, 403-406.
40. Russo AF, Clark MS and Lanigan TM. (in press). Genetic Mechanisms in Multiple Endocrine Neoplasia Type 2. Nelkin BD. (ed). Landes Co: Austin TX.
41. Santoro M, Rosati R, Grieco M, Berlingieri MT, Luca-Colucci D'Amato G, de Franciscis V and Fusco A. (1990). Oncogene, 5, 1595-1598.
42. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, Di Fiore PP. (1995). Science, 267, 381-383.
43. Schneider R. (1992). Trends Bioch. Sci., 17, 468-469.
44. Schuffenecker I, Billaud M, Calender A, Chambe B, Ginet N, Calmettes C, Modigliani E, Lenoir GM and the GETC. (1994). Hum. Mol. Genet., 3, 1939-1943.
45. Schuchardt A, D'Agati V, Larsson-Bomberg L, Costantini F and Pachnis V. (1994). Nature, 367, 380-383.
46. Songyang Z, Carraway III KL, Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C, Lorenzo MJ, Ponder BAJ, Mayer BJ and Cantley LC. (1995). Nature, 373, 536-539.
47. Tahira T, Ishizaka Y, Itoh F, Sugimura T and Nagao M. (1990). Oncogene, 5, 97-102.
48. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H and Hiai H. (1988). Oncogene, 3, 571-578.
49. Taniguchi M, Iwamoto T, Hamaguchi M, Matsuyama M and Takahashi M. (1991). Bioch. Biophys. Res. Commun., 181, 416-422.
50. Treanor JJS, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE and Rosenthal A. (1996). Nature, 382, 80-83.
51. Trupp M, Arenas E, Fainzilber M, Nilsson AS, Sieber BA, Grigoriou M, Kilkenny C, Salazar-Gruesco E, Pachnis V, Arumäe U, Sariola H, Saarma M and Ibañez CF. (1996). Nature, 381, 785-789.
52. Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M and Asai, J. (1995). Oncogene, 10, 191-198.
53. van der Geer P, Hunter T and Lindberg RA. (1994). Ann. Rev. Cell. Biol., 10, 251-337.
54. van Grunsven LA, Billon N, Savatier P, Thomas A, Urdiales JL and Rudkin BB. (1996). Oncogene, 12, 1347-1356.
55. van Weering DHJ, Medema JP, van Puijenbroek, Burgering BMT, Baas PD and Bos JL. (1995). Oncogene, 11, 2207-2214.